Clinical Trials

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory CancersClinicalTrials.gov ID NCT03388632Sponsor National Cancer Institute (NCI)Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party) Interleukin-34 Level in Periodontal DiseaseClinicalTrials.gov ID NCT05962567Sponsor Ain Shams UniversityInformation provided by Nada Zidan, Ain Shams University (Responsible Party) TNFalpha and Interleukin 2 [READ MORE]

Clinical Trials of interest to cytokine & interferon researchers [READ MORE]

By Marta Catalfamo Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure (Virginia-ART4) Principal Investigators: Benjamin Van Tassell, PharmD. Virginia Commonwealth University. Richmond, Virginia, United States, 23298 Contact: Benjamin Van Tassell, PharmD. Phone: 804-828-4583 ClinicalTrials.gov Identifier: NCT05177822   Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia Principal Investigators: [READ MORE]

By Marta Catalfamo Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (DiTuSarc) ClinicalTrials.gov Identifier: NCT05080790  Contact: Daniel Pink, Dr.              033631 73527            [email protected] Contact: Melanie Prause              069 7601 4211          [email protected] Sponsors and Collaborators Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest EUSA Pharma, Inc. [READ MORE]